COVID-19: Protecting our Employees

Our employees make Boehringer Ingelheim. Their daily commitment helps to ensure the continued supply of our medicines to those who need them, and engage in various initiatives to combat COVID-19. We have taken precautions to protect their health and mitigate the risk of COVID-19 affecting our organisation.

In the course of the spread of the disease, we have taken a proactive approach and introduced early travel restrictions, with currently global effect. As an organisation, Boehringer Ingelheim has state-of-the-art technology and equipment in place to facilitate the digital workplace. Our employees have the equipment and technical capabilities to log into their business systems from home. Here in Ireland, our colleagues are working from home. This ensures the supply of our medicines to humans and animals remains uninterrupted.  With regard to the implementation of measures, we strictly follow the guidance of local authorities and international experts, including the World Health Organization (WHO).

 

NP-IE-100280 | March 2020

More related content